Incyte Corp (NQ: INCY )

89.71 USD +0.02 (+0.02%)

Streaming Delayed Price Updated: 2:45 PM EDT, Oct 26, 2020 Add to My Watchlist

Price and Volume

Volume	341,507
Open	88.82
Bid (Size)	89.68 (1)
Ask (Size)	89.74 (1)
Prev. Close	89.69
Today's Range	88.56 - 90.28
52wk Range	62.48 - 110.36
Shares Outstanding	211,969,163
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen

October 08, 2020

Further results from NIAID-sponsored ACTT-2 Trial Presented Today

Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer

October 22, 2020

Performance

YTD	+4.35%	+4.35%
1 Month	+3.65%	+3.65%
3 Month	-12.13%	-12.13%
6 Month	-12.89%	-12.89%
1 Year	+12.33%	+12.33%

More News

Clinical Trials Delivering New Optimism in Fight Against Triple-Negative Breast Cancer

October 22, 2020

CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis

September 18, 2020

Incyte to Report Third Quarter Financial Results

October 20, 2020

Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics

October 05, 2020

Investors Are Scrambling To Get Ahead Of The Oncology Drug Market Boom; 1 Company Could Revolutionize The Industry

September 24, 2020

MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas

September 17, 2020

PG&E Larger Than S&P 500 Component Incyte

October 22, 2020

First Week of June 2021 Options Trading For Incyte (INCY)

October 16, 2020

Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal

September 18, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.